AtriCure (ATRC) director Deborah Telman awarded 6,144 restricted shares

Rhea-AI Filing Summary

Telman Deborah H reported acquisition or exercise transactions in this Form 4 filing.

AtriCure, Inc. director Deborah H. Telman received a grant of 6,144 shares of Common Stock as a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest on the one-year anniversary of the grant date. Following this award, she holds 28,328 shares of AtriCure common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Telman Deborah H

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	6,144	$0.00	--

Holdings After Transaction: Common Stock — 28,328 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted shares granted: 6,144 shares Price per granted share: $0.00 per share Shares owned after grant: 28,328 shares +1 more

4 metrics

Restricted shares granted 6,144 shares Restricted Stock Award under 2023 Stock Incentive Plan

Price per granted share $0.00 per share Equity compensation grant, not market purchase

Shares owned after grant 28,328 shares Total direct holdings following the award

Vesting schedule One-year cliff vesting Shares vest on one-year anniversary of grant date

Key Terms

Restricted Stock Award, 2023 Stock Incentive Plan, vest, Form 4

4 terms

Restricted Stock Award financial

"acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan"

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

2023 Stock Incentive Plan financial

"pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan"

vest financial

"The shares will vest upon the one-year anniversary of the grant date"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Form 4 regulatory

"reported this equity grant on a Form 4 insider transaction filing"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Telman Deborah H

(Last) (First) (Middle)

7555 INNOVATION WAY

(Street)

MASON OHIO 45040-9695

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AtriCure, Inc. [ ATRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/18/2026		A		6,144(1)	A	$0	28,328	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.

Remarks:

	/s/ Allison Walker as Attorney-in-fact for Deborah H. Telman	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did AtriCure (ATRC) director Deborah Telman report in this Form 4?

Deborah H. Telman reported receiving 6,144 shares of AtriCure common stock. The shares were granted as a Restricted Stock Award and increase her direct holdings to 28,328 shares after the transaction.

Was the AtriCure (ATRC) Form 4 transaction a market purchase or sale?

The transaction was not a market purchase or sale. It was a grant of 6,144 shares as a Restricted Stock Award with a zero dollar price per share, reflecting compensation rather than open-market trading activity.

When do the 6,144 restricted AtriCure (ATRC) shares granted to Deborah Telman vest?

The 6,144 restricted shares granted to Deborah H. Telman will vest on the one-year anniversary of the grant date. This means she must remain eligible through that one-year period for the award to fully vest.

How many AtriCure (ATRC) shares does Deborah Telman own after this restricted stock grant?

After the Restricted Stock Award, Deborah H. Telman directly owns 28,328 shares of AtriCure common stock. This total includes the newly granted 6,144 restricted shares reported in the Form 4 filing.

Under which plan was the AtriCure (ATRC) Restricted Stock Award to Deborah Telman granted?

The 6,144-share Restricted Stock Award to Deborah H. Telman was granted under the AtriCure, Inc. 2023 Stock Incentive Plan. This plan provides equity-based compensation such as restricted stock awards to eligible participants.